Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

  • This share is currently suspended. It was suspended at a price of 130.00
  • There is currently no data for DLAR

Trading Statement

13 Apr 2021 07:00

RNS Number : 2105V
De La Rue PLC
13 April 2021
 

13 April 2021

DE LA RUE PLC

TRADING UPDATE

De La Rue plc (LSE: DLAR) ("De La Rue" or the "Company") today announces a trading update for financial year 2020/21, which ended 27 March 2021.

 

As a result of continued positive trading, the Board expects Adjusted Operating Profit for the financial year 2020/21 to be around the top end of the £36 million to £37 million range previously indicated in the Company's trading update of 28 January 2021.

End of year Net Debt was approximately £53 million, which is lower than market expectations(1) by approximately £21 million. This is mainly due to lower capital expenditure during the year, consistent with adjustments made to the timing of capital spend as the Turnaround Plan has evolved. Total aggregate 3-year cash investment for the Turnaround Plan remains unchanged.

Due to the positive outcome of the financial year, the Company has repaid all the money received from HM Government's Coronavirus Job Retention Scheme. Furlough payments received under this scheme totalled approximately £0.4m.

In the results for financial year 2020/21, the Company will record non-cash exceptional asset impairment and accelerated depreciation charges of approximately £13 million on historic assets, as a result of the closure of the Gateshead banknote printing operations in December 2020. Of this, approximately £12m was recorded in the second half of the year following finalisation of the detailed plans for which assets currently are expected to have any ongoing use within the group.

De La Rue expects to announce its results for the full year ended 27 March 2021 on 26 May 2021.

De La Rue plc's LEI code is 213800DH741LZWIJXP78.

(1). Market expectations are based on the average of published notes from Investec and Numis Securities.

Enquiries:

 

De La Rue plc

 

+44 (0) 7387 122645

Clive Vacher

 

Chief Executive Officer

Rob Harding

 

Chief Financial Officer

Matthew Rose

 

Director of Tax, Treasury and Investor Relations

 

Brunswick Group LLP +44 (0)207 404 5959

Stuart Donnelly/Ed Brown

 

 

Cautionary note regarding forward-looking statements

 

This announcement includes statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "anticipates", "expects", "intends", "plans", "may", "will", "could", "shall", "risk", "aims", "predicts", "continues", "assumes", "positioned" or "should" or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this announcement and include statements regarding the intentions, beliefs or current expectations of the directors, De La Rue or the Group concerning, amongst other things, the results of operations, financial condition, liquidity, prospects, growth and strategies of De La Rue and the industry in which it operates.

By their nature, forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors because they relate to events and depend on circumstances that will occur in the future whether or not outside the control of the Company. Past performance cannot be relied upon as a guide to future performance and should not be taken as a representation or assurance that trends or activities underlying past performance will continue in the future. Accordingly, investors or potential investors should not place undue reliance on these forward-looking statements. The Group's actual results of operations, financial condition, liquidity and the development of the industry in which it operates may differ materially from the impression created by the forward-looking statements contained in this announcement. In addition, even if the results of operations, financial condition and liquidity of the Group and the development of the industry in which it operates, are consistent with the forward-looking statements contained in this announcement, those results or developments may not be indicative of results or developments in subsequent periods.

Other than in accordance with its legal or regulatory obligations, De La Rue does not undertake any obligation to update these forward-looking statements, which speak only as at the date of this announcement, and will not publicly release any revisions that may be made to these forward-looking statements, which may result from events or circumstances arising after the date of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTITMRTMTBBBFB
Date   Source Headline
9th Jul 20201:38 pmRNSHolding(s) in Company
8th Jul 20203:58 pmRNSDirector/PDMR Shareholding
6th Jul 20202:20 pmRNSResults of Capital Raising and General Meeting
3rd Jul 20202:31 pmRNSHolding(s) in Company
2nd Jul 20205:46 pmRNSHolding(s) in Company
1st Jul 202010:46 amRNSBlock listing Interim Review
23rd Jun 202011:48 amRNSHolding(s) in Company
17th Jun 20202:15 pmRNSPublication of Prospectus
17th Jun 20207:01 amRNSProposed Capital Raising
17th Jun 20207:00 amRNS2019/20 FULL YEAR RESULTS AND ANNUAL REPORT 2020
16th Jun 20207:00 amRNSSFO INVESTIGATION CLOSURE
1st Jun 20207:00 amRNSTRADING AND COVID-19 UPDATE
6th May 20207:00 amRNSFULL YEAR ANNOUNCEMENT DATE
27th Apr 20205:57 pmRNSDisclosure of Rights Attached to Equity Shares
1st Apr 202012:28 pmRNSTotal Voting Rights
31st Mar 20207:00 amRNSTrading Update
27th Mar 20209:31 amRNSHolding(s) in Company
24th Mar 202010:35 amRNSHolding(s) in Company
9th Mar 20205:28 pmRNSHolding(s) in Company
5th Mar 20205:44 pmRNSHolding(s) in Company
25th Feb 20205:48 pmRNSHolding(s) in Company
25th Feb 20207:00 amRNSTURNAROUND AND TRADING UPDATE
10th Feb 20202:00 pmRNSCHIEF FINANCIAL OFFICER APPOINTMENT
4th Feb 20206:05 pmRNSDirector Declaration
3rd Feb 20202:38 pmRNSTotal Voting Rights
29th Jan 20203:53 pmRNSHolding(s) in Company
24th Jan 202010:44 amRNSDirectorate Change
7th Jan 20205:13 pmRNSHolding(s) in Company
7th Jan 20205:09 pmRNSDirector/PDMR Shareholding
7th Jan 20205:05 pmRNSDirector/PDMR Shareholding
6th Jan 20204:58 pmRNSHolding(s) in Company
2nd Jan 202010:58 amRNSBlock listing Interim Review
2nd Jan 202010:52 amRNSTotal Voting Rights
19th Dec 20192:58 pmRNSDirector/PDMR Shareholding
16th Dec 201912:46 pmRNSDirector/PDMR Shareholding
4th Dec 20196:19 pmRNSDirector/PDMR Shareholding
3rd Dec 20193:36 pmRNSHolding(s) in Company
2nd Dec 201910:07 amRNSTotal Voting Rights
29th Nov 20192:09 pmRNSDirector/PDMR Shareholding
28th Nov 20194:20 pmRNSDirector/PDMR Shareholding
26th Nov 20196:44 pmRNSDirector/PDMR Shareholding
26th Nov 20197:00 amRNS2019/20 HALF YEAR RESULTS
21st Nov 20193:00 pmRNSAdditional Listing
13th Nov 20193:03 pmRNSHolding(s) in Company
8th Nov 20194:56 pmRNSHolding(s) in Company
31st Oct 20195:05 pmRNSTotal Voting Rights
30th Oct 20197:00 amRNSTrading Update
14th Oct 20193:59 pmRNSCompletion of Sale of ID Business
7th Oct 20195:53 pmRNSHolding(s) in Company
7th Oct 20194:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.